School of Medicine, Keele University, Keele, Staffordshire, Newcastle upon Tyne, ST5 5BG, UK.
Institute for Global Health, Keele University, Keele, Staffordshire, Newcastle upon Tyne, ST5 5BG, UK.
Rheumatol Int. 2021 Jul;41(7):1221-1231. doi: 10.1007/s00296-021-04838-y. Epub 2021 Apr 27.
Evidence from the Global Burden of Disease studies suggests that osteoarthritis (OA) is a significant cause of disability globally; however, it is less clear how much of this burden exists in low-income and lower middle-income countries. This study aims to determine the prevalence of OA in people living in low-income and lower middle-income countries. Four electronic databases (MEDLINE, EMBASE, CINAHL and Web of Science) were systematically searched from inception to October 2018 for population-based studies. We included studies reporting the prevalence of OA among people aged 15 years and over in low-income and lower middle-income countries. The prevalence estimates were pooled across studies using random effects meta-analysis. Our study was registered with PROSPERO, number CRD42018112870.The search identified 7414 articles, of which 356 articles were selected for full text assessment. 34 studies were eligible and included in the systematic review and meta-analysis. The pooled prevalence of OA was 16·05% (95% confidence interval (CI) 12·55-19·89), with studies demonstrating a substantial degree of heterogeneity (I = 99·50%). The pooled prevalence of OA was 16.4% (CI 11·60-21.78%) in South Asia, 15.7% (CI 5·31-30·25%) in East Asia and Pacific, and 14.2% (CI 7·95-21·89%) in Sub Saharan Africa. The meta-regression analysis showed that publication year, study sample size, risk of bias score and country-income categories were significantly associated with the variations in the prevalence estimates. The prevalence of OA is high in low-income and lower middle-income countries, with almost one in six of the study participants reported to have OA. With the changing population demographics and the shift to the emergence of non-communicable diseases, targeted public health strategies are urgently needed to address this growing epidemic in the aging population.
来自全球疾病负担研究的证据表明,骨关节炎(OA)是全球致残的一个重要原因;然而,在低收入和中低收入国家,这种负担有多少尚不清楚。本研究旨在确定生活在低收入和中低收入国家的人群中 OA 的患病率。从 2018 年 10 月起,我们系统地在四个电子数据库(MEDLINE、EMBASE、CINAHL 和 Web of Science)中搜索了基于人群的研究。我们纳入了报告 15 岁及以上人群 OA 患病率的研究。使用随机效应荟萃分析汇总了研究间的患病率估计值。我们的研究在 PROSPERO 注册,编号为 CRD42018112870。搜索共确定了 7414 篇文章,其中 356 篇文章进行了全文评估。34 项研究符合纳入标准,并纳入了系统评价和荟萃分析。OA 的总患病率为 16.05%(95%置信区间 12.55-19.89),研究显示存在很大程度的异质性(I=99.50%)。南亚 OA 的总患病率为 16.4%(95%置信区间 11.60-21.78%),东亚和太平洋地区为 15.7%(95%置信区间 5.31-30.25%),撒哈拉以南非洲为 14.2%(95%置信区间 7.95-21.89%)。元回归分析显示,发表年份、研究样本量、偏倚风险评分和国家收入类别与患病率估计值的变化显著相关。OA 在低收入和中低收入国家的患病率较高,近六分之一的研究参与者报告患有 OA。随着人口结构的变化和向非传染性疾病的转变,迫切需要采取有针对性的公共卫生策略来应对这一在老年人群中不断增长的流行疾病。